BMA hits back after NHS says less than a third of resident doctors joined strike
The number that took part in the five-day walkout was down by 7.5% (1,243) on the previous round of industrial action in July last year, according to an early analysis of management information collected by NHS England.
But the British Medical Association rejected this, saying complex work schedules and doctors taking leave make this information 'almost impossible to know'.
NHS England said it maintained care for an estimated 10,000 more patients during the latest doctors' strike compared with last year's, and 93% of planned operations, tests and procedures went ahead.
In previous walkouts, the majority of non-urgent care was postponed.
Health Secretary Wes Streeting said: 'A majority of resident doctors didn't vote for strike action and data shows that less than a third of residents took part.
'I want to thank those resident doctors who went to work for their commitment to their patients and to our shared mission to rebuild the NHS.'
He said it is time to 'move past the cycle of disruption'.
He added: 'I want to end this unnecessary dispute and I will be urging the BMA to work with the Government in good faith in our shared endeavour to improve the working lives of resident doctors, rather than pursuing more reckless strike action.'
The BMA said it recognised the efforts that senior doctors and healthcare workers made during the strike to provide care to patients, but it disputed the figure set out by the NHS.
It said: 'NHS England's claim that the majority of England's 77,000 resident doctors chose to 'join the NHS-wide effort to keep the services open' requires a huge stretch of the imagination, given it is almost impossible to know the exact number of residents working on any given day because of complex work patterns, on-call schedules and the strike spread across a weekend.
'Added to that, in July many doctors are using up their remaining annual leave before their new posts start and would therefore not show up as striking.
'We look forward to seeing hard and fast data on NHS England's claim.
'The strike could have been averted, as could any future ones, if Mr Streeting had come, and will come, to the table with a credible offer that resident doctors in England can accept.'
NHS chief executive Sir James Mackey noted care was still disrupted for thousands of people and said a repeat of strike action will be 'unacceptable'.
'I would urge the resident doctors committee to get back to the negotiating table and work with us and the Government on the meaningful improvements we can make to resident doctors' working lives.'
NHS Providers, which represents hospital trusts, said the walkout took a toll and trusts are concerned about potential wider industrial action in the health service.
Saffron Cordery, NHS Providers deputy chief executive, said: 'This dispute can't drag on.
'The union says resident doctors want this to be their last strike. With talks due to resume, let's hope so. Bringing disruptive strikes – where the only people being punished are patients – to an end must be a priority.
'We're concerned, as trusts worked hard to minimise disruption and to keep patients safe during the resident doctors' strike, by the threat of wider industrial action in the NHS.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
4 minutes ago
- BBC News
Cardiff mum wants NHS changes after newborn baby's death
A mum whose daughter died at just 20 hours old after she was left on her own during labour has said major changes are needed to stop more Iris Thomas died on 10 October 2022 at Cardiff's University Hospital of Wales due to a lack of oxygen when Emily Brazier gave birth alone and in a coma after a reaction to pain said Liliwen's death "must not be in vain" and wants all health boards to change their policies on pain relief in labour and Welsh government said there were "mechanisms in place for learning to be shared". Emily, 33 from Cardiff, said she felt the inquest gave her family "some justice".She added: "For the coroner to say that this should not have happened and that she should be here is something we needed to hear." The harrowing details of Liliwen's birth are "seared into" Emily's mind - she was alone in the induction suite of the maternity unit, where women stay during the early stages of labour."I was just puffing on gas and air, I couldn't move, I couldn't press a call bell, I couldn't open my eyes, it was as if I was trapped in my own body."Emily had been given significant amounts of pethidine and codeine with no-one monitoring her use of gas and air."I just thought 'someone will come and help me - surely, someone will help me.' But nobody did." Emily's partner Rhodri Thomas, 41, was not with her because of Cardiff and Vale health board's policy at the time did not allow partners on the ward overnight, unless their partner was in active records show nobody checked on Emily for an hour during which time she gave birth to Liliwen as she drifted in and out of a coma and she woke up to see "so much blood and a baby lying there".Emily said, when Rhodri arrived, no-one told him of the seriousness of the situation and the first thing she said to him was: "I don't know if our baby is alive."The following hours were filled with visits from family members who "said hello and goodbye" to Liliwen after it became clear she would not still feels "unbelievable guilt" about her life support machine being switched off and Liliwen died in her father's arms. The health board said it sent its "deepest sympathies" to the family and was "fully committed to learning from this tragic event".It added: "In response to the concerns raised, we have implemented robust changes to staffing, escalation protocols and psychological support for both families and staff."A spokesperson added the board would "welcome the opportunity to meet with Liliwen's family to share the actions taken". Now, the family want changes to maternity care, as well as changes they believe could help all families whose relative suffers death or injury in the inquest heard fundamental changes had been made at the health board since 2022, including only allowing women to use gas and air under supervision, reducing doses of other painkillers and reassessing their induction said this must now be implemented at all health boards by the Welsh government."It feels like every other week there are more cases about baby injury or death and maternity services are on their last legs," she said."If they can implement the changes that Cardiff and Vale have, it's a step closer to this not happening again." The family are also concerned that Liliwen's death was investigated by an officer within the health board."For families it just leaves an element of bias - of cover ups - it just doesn't sit well and it doesn't help the grieving process," Emily wants an independent body set up to deal with cases across Wales - something that already happens in England through the HSSIB or MSNI in maternity avenue for change could be through a review of NICE guidance on pain relief in labour - something raised by Coroner Rachel Knight in a Prevention of Future Death report following Liliwen's the body that issues guidance across the NHS in Wales and England, has until 3 September to respond."It feels like Liliwen's death won't be in vain if we can achieve the change that we feel is needed," said Emily."Then I can say I have done everything in her name and to think that this will not happen to another family is a sense of justice for us as well." The Welsh government said patient safety was "paramount" and it was aware of the findings at Cardiff and Vale health added: "An independent assessment of all Welsh maternity and neonatal services began in July to assess how all maternity services are performing against national guidelines." The family's lawyers, Slater and Gordon are still negotiating a claim against the health board and senior associate Lara Bennett called Liliwen's death "absolutely tragic and... entirely avoidable".She added that it was "vital" that all health boards in Wales adopted the new policies to ensure the mistakes that led to Liliwen's death are not allowed to happen again. If you have been affected by the issues raised in this story you can visit the BBC Action Line for details of organisations who can offer support.
The Sun
34 minutes ago
- The Sun
University puts up ‘bonkers' posters warning its students not to eat conkers
A UNIVERSITY launched a 'bonkers' campaign warning its students not to eat conkers. East Anglia University has put up posters showing a conker in a red circle with a cross through it. Above the image is written, 'Do not eat conkers!' and below, 'These are not chestnuts and eating them will make you unwell'. Bosses put up the posters in the international student study centre fearing a new intake of Chinese students might think they are edible. Around 1,000 of the 17,000 students at the Norwich university hail from China. It is feared some new arrivals could confuse conkers — known as horse chestnuts — with water chestnuts, which are prized in China for their crunchy texture and mild sweetness. Horse chestnuts, however, contain a toxin called aesculin which can cause abdominal pain, nausea and vomiting. A source said: 'The uni looks out for student welfare and thought this was an area they may need guidance on.' The university said: 'As far as we're aware, no students have attempted to eat conkers and we'd like to keep it that way. 'The posters were prompted by a member of staff who previously worked with Chinese students and recalled similar confusion elsewhere. 'It's part of our broader commitment to student wellbeing.'
Daily Mirror
an hour ago
- Daily Mirror
Weight loss pill that helped patients shift 12% of body mass may soon be on NHS
A weight-loss tablet, which could be a cheaper and easier alternative to jabs and has seen patients during a trial lose up to almost 2st, could soon be available on the NHS A powerful new generation of weight-loss pill that could provide hope for millions of patients is set to be considered by regulators for NHS approval. A trial found overweight people taking the medication lost up to almost 2st – or 12% of their body weight – after 18 months. The maker, US firm Lilly, said it will seek the go-ahead by regulators for the drug orforglipron. It could be a cheaper and easier alternative to weight-loss jabs, which have to be refrigerated. The daily tablet is a GLP-1 agonist, which can cut appetite. Like jabs, the pill mimics the effects of hormones that make us feel full. Lilly also makes weight-loss jab Mounjaro. It comes after the NHS warned mouth symptom could be life-shortening disease. Kenneth Custer, of Lilly, said: 'We're working to transform obesity care with a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments. 'We are planning to submit orforglipron for regulatory review by year-end.' It will need to be approved as safe by the Medicines and Healthcare products Regulatory Agency before the National Institute for Health and Care Excellence decides if it is cost-effective for the NHS. The Mirror understands guidance is expected next year on whether it will be available on the health service. The study found 60% of people on the highest dose of orforglipron lost at least 10% of their body weight. While 40% of people shed at least 15% of their body weight. The study of 3,127 overweight adults also found benefits such as better cholesterol. Lilly said the safety profile of the tablet is similar to other GLP-1 drugs, with gastrointestinal issues the most common side effect. Dr Simon Cork, senior lecturer in physiology at Anglia Ruskin University, said: 'These early results on the effectiveness of orforglipron in promoting clinically significant weight loss are a positive step forward in the development of this class of drugs. 'Their effects on weight loss are not as profound as that seen in [jabs]. 'Nevertheless, that this medication is an oral form, rather than injectable, will likely be seen as more tolerable for many. Manufacturing costs are also anticipated to be significantly lower.' An estimated 1.5 million people in the UK use weight-loss medication, most privately. Mounjaro was due to be rolled out across the NHS in England from June 23 for those with the highest clinical need, but a probe found only eight of 42 NHS integrated care boards are providing it at present. Nearly half of boards say they will cap the number they treat due to lack of funding. NHS England says the plan is for jabs to bemore widely available. Figures suggest about 29% of adults are obese. Another new study has found GLP-1s may have other benefits such as improving Alzheimer's and liver disease.
